WHAT YOU NEED TO KNOW ABOUT ELMIRON
Elmiron is a prescription medication used to treat interstitial cystitis (IC), a widespread condition known as “pain bladder syndrome.”
Recent research indicates that long-term use of Elmiron may cause serious eye disease affecting the retina.
Reports indicate that close to 25% of patients with long-term exposure to the drug showed signs of unusual retinal damage and vision problems.
HOW CAN WE HELP
If you have used Elmiron and have suffered maculopathy, an eye disorder affecting the light sensitive part retina, you may have a legal claim. If you would like more information about your legal options, please give us a call at 800.887.8029 or fill out our free case review on the right. All consultations are free and confidential.
Elmiron, manufactured by Janssen Pharmaceuticals, is a prescription medication used to treat interstitial cystitis, which is often referred to as known as painful bladder syndrome. This disorder most frequently affects women and can cause chronic pelvic pain and the sensation of needing to go to the bathroom more often.
Recently, ophthalmologists and researchers at the Emory Eye Center noted a unique pigmentary maculopathy associated with long term exposure to Elmiron (pentosan polysulfate sodium). Pigmentary maculopathy is a disorder that affects the macula, or the central portion of the retina, which is the light-sensitive portion of the eye. Those findings led ophthalmologists to further examine the records of patients who had taken the drug over the course of several years. Of the patients they interviewed, close to 25% showed evidence of retinal damage.
These findings have led researchers to recommend eye exams to monitor changes in the retina, which left untreated, may cause blindness. Symptoms may include:
- Dimming of vision
- Blurred or distorted vision
- Defects in peripheral vision
- Vision loss
IN THE NEWS
TALK TO A LAWYER
If you have taken Elmiron and suffer from or have been diagnosed with macular disease or retinal damage, you may be entitled to compensation. Complete the free case review form on the right or call 800.887.8029 for a free and confidential consultation.